NASDAQ:GTBP | ROE | GT Biopharma, Inc.

Complete source-backed roe history.

Available history
2010-12-31 to 2026-06-30
Data captured

Historical ROE

DateROE
2026-06-30-453.15%
2026-03-31-551.77%
2025-12-31-687.18%
2025-09-30-1261.13%
2025-06-30147.37%
2025-03-311191.02%
2024-12-31788.14%
2024-09-30-588.89%
2024-06-30-206.14%
2024-03-31-181.40%
2023-12-31-101.62%
2023-09-30-102.14%
2023-06-30-124.83%
2023-03-31-120.06%
2022-12-31-177.98%
2022-09-30-208.86%
2022-06-30-206.57%
2022-03-31-189.87%
2021-12-31-264.78%
2021-09-30-145.19%
2021-06-30-120.43%
2021-03-31-234.27%
2020-12-3196.14%
2020-09-3078.84%
2020-06-30187.64%
2020-03-31121.52%
2019-12-31200.14%
2019-09-30226.45%
2019-06-30-2755.27%
2019-03-31-2532.00%
2018-12-31-2279.56%
2018-09-30-1960.35%
2018-06-30-63.33%
2018-03-31-59.15%
2017-12-31-57.28%
2017-09-30-60.00%
2017-06-30125.70%
2017-03-31117.28%
2016-12-31-51.62%
2016-09-3078.55%
2016-06-3073.13%
2016-03-31-67.95%
2015-12-3152.93%
2015-09-3056.96%
2015-06-3072.10%
2015-03-3187.39%
2014-12-3179.42%
2014-09-3047.75%
2014-06-3018.75%
2014-03-3120.33%
2013-12-318.27%
2013-09-3015.60%
2013-06-3035.90%
2013-03-3177.29%
2012-12-3181.61%
2012-09-3088.94%
2012-03-3169.41%
2011-12-3172.53%
2011-09-3065.12%

Annual ROE

DateROE
2025-12-31-489.96%
2024-12-31788.14%
2023-12-31-101.62%
2022-12-31-177.98%
2021-12-31-264.78%
2020-12-3196.14%
2019-12-31200.14%
2018-12-31-2279.56%
2017-12-31-57.28%
2016-12-31-51.62%
2015-12-3152.93%
2014-12-3179.42%
2013-12-317.91%
2012-12-3181.61%
2011-12-3172.53%
2010-12-3154.76%